{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:51:34Z","timestamp":1790553094223,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":700,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","award":["UL1RR024143"],"award-info":[{"award-number":["UL1RR024143"]}],"id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/jid.2013.269","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T09:46:29Z","timestamp":1371203189000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Dominant Th1 and Minimal Th17 Skewing in Discoid Lupus Revealed by Transcriptomic Comparison with Psoriasis"],"prefix":"10.1016","volume":"134","author":[{"given":"Ali","family":"Jabbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte","family":"Su\u00e1rez-Fari\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judilyn","family":"Fuentes-Duculan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Cueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Andrew G.","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2013.269_bb0010","doi-asserted-by":"crossref","first-page":"823085","DOI":"10.1155\/2012\/823085","article-title":"Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new","volume":"2012","author":"Alunno","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1038\/jid.2013.269_bb0015","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.269_bb0020","first-page":"255","article-title":"T helper 17 cell population in lupus erythematosus","volume":"48","author":"Balanescu","year":"2010","journal-title":"Rom J Intern Med"},{"key":"10.1038\/jid.2013.269_bb0025","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1371\/journal.pmed.0030491","article-title":"Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus","volume":"3","author":"Bauer","year":"2006","journal-title":"PLoS Med"},{"key":"10.1038\/jid.2013.269_bb0030","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2013.269_bb0035","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/10.17.1793","article-title":"Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies","volume":"10","author":"Bowcock","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1038\/jid.2013.269_bb0040","first-page":"365","article-title":"Treatment of alopecia areata: modern principles and perspectives","volume":"132","author":"Brajac","year":"2010","journal-title":"Lijec Vjesn"},{"key":"10.1038\/jid.2013.269_bb0045","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2133.2012.10825.x","article-title":"The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score","volume":"166","author":"Braunstein","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2013.269_bb0050","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1369\/0022155410398000","article-title":"Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythematosus and dermatomyositis","volume":"59","author":"Chang","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"10.1038\/jid.2013.269_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10875-009-9365-x","article-title":"Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity","volume":"30","author":"Chen","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1038\/jid.2013.269_bb0060","doi-asserted-by":"crossref","first-page":"R150","DOI":"10.1186\/ar3100","article-title":"Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus","volume":"12","author":"Dolff","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/jid.2013.269_bb0065","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/jid.2011.140","article-title":"Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation","volume":"131","author":"Fridman","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.269_bb0070","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gronhagen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2013.269_bb0075","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/jid.2009.173","article-title":"Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin","volume":"129","author":"Gudjonsson","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.269_bb0080","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.4049\/jimmunol.181.10.7420","article-title":"Low expression of the IL-23\/Th17 pathway in atopic dermatitis compared to psoriasis","volume":"181","author":"Guttman-Yassky","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/jid.2013.269_bb0085","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMoa1110556","article-title":"JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis","volume":"366","author":"Harrison","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2013.269_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cellimm.2010.05.004","article-title":"Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus","volume":"264","author":"Henriques","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1038\/jid.2013.269_bb0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1756-185X.2011.01654.x","article-title":"Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients","volume":"15","author":"Higgs","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1038\/jid.2013.269_bb0100","first-page":"17","article-title":"Role of the immune system and immunological circuits in psoriasis","volume":"146","author":"Jabbari","year":"2011","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1038\/jid.2013.269_bb0105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/jid.2011.267","article-title":"Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes","volume":"132","author":"Jabbari","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.269_bb0110","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1002\/art.20798","article-title":"Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus","volume":"50","author":"Kirou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2013.269_bb0115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.5603\/FHC.2011.0088","article-title":"Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus","volume":"49","author":"Kleczynska","year":"2011","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1038\/jid.2013.269_bb0120","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2013.269_bb0125","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"key":"10.1038\/jid.2013.269_bb0130","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.269_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2353\/ajpath.2007.061067","article-title":"The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis","volume":"171","author":"Mee","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2013.269_bb0140","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3899\/jrheum.100293","article-title":"The relation of interleukin 17 (IL-17) and IL-23 to Th1\/Th2 cytokines and disease activity in systemic lupus erythematosus","volume":"37","author":"Mok","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1038\/jid.2013.269_bb0145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2013.269_bb0150","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2013.269_bb0155","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2230.2010.03996.x","article-title":"Expression of interleukin-17 is correlated with interferon-alpha expression in cutaneous lesions of lupus erythematosus","volume":"36","author":"Oh","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1038\/jid.2013.269_bb0160","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ncprheum0815","article-title":"Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus","volume":"4","author":"Pan","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1038\/jid.2013.269_bb0165","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"key":"10.1038\/jid.2013.269_bb0170","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"Papp","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2013.269_bb0175","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJM196311282692201","article-title":"Chronic discoid lupus erythematosus","volume":"269","author":"Rothfield","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2013.269_bb0180","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1136\/ard.2011.154104","article-title":"Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus","volume":"70","author":"Sanchez","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/jid.2013.269_bb0185","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar2964","article-title":"Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus","volume":"12","author":"Shah","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/jid.2013.269_bb0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(97)70279-2","article-title":"T-cell cytokine network in cutaneous lupus erythematosus","volume":"36","author":"Stein","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2013.269_bb0195","doi-asserted-by":"crossref","first-page":"e10247","DOI":"10.1371\/journal.pone.0010247","article-title":"Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA)","volume":"5","author":"Suarez-Farinas","year":"2010","journal-title":"PLoS One"},{"key":"10.1038\/jid.2013.269_bb0200","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.269_bb0205","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2013.269_bb0210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejim.2010.03.004","article-title":"IL-17 in cutaneous lupus erythematosus","volume":"21","author":"Tanasescu","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1038\/jid.2013.269_bb0215","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/archderm.136.12.1497","article-title":"Detection of type 1 cytokines in discoid lupus erythematosus","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2013.269_bb0220","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2","article-title":"Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992","volume":"42","author":"Uramoto","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2013.269_bb0225","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2013.269_bb0230","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1110557","article-title":"A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2013.269_bb0235","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrrheum.2012.106","article-title":"New insights into mechanisms of therapeutic effects of antimalarial agents in SLE","volume":"8","author":"Wallace","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1038\/jid.2013.269_bb0240","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1365-2133.2005.06784.x","article-title":"Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA","volume":"153","author":"Wenzel","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2013.269_bb0245","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J Pathol"},{"key":"10.1038\/jid.2013.269_bb0250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00403-008-0892-8","article-title":"Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus","volume":"301","author":"Wenzel","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1038\/jid.2013.269_bb0255","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2009.08.046","article-title":"Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes","volume":"124","author":"Zaba","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/jid.2013.269_bb0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11033-009-9533-3","article-title":"Increased serum interleukin 17 in patients with systemic lupus erythematosus","volume":"37","author":"Zhao","year":"2010","journal-title":"Mol Biol Rep"},{"key":"10.1038\/jid.2013.269_bb0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physiolgenomics.00157.2002","article-title":"Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array","volume":"13","author":"Zhou","year":"2003","journal-title":"Physiol Genomics"}],"updated-by":[{"DOI":"10.1038\/jid.2014.41","type":"addendum","label":"Addendum","source":"publisher","updated":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000}}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15364393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15364393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:02:08Z","timestamp":1743958928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15364393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0022202X15364393"],"URL":"https:\/\/doi.org\/10.1038\/jid.2013.269","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718025941.793479699","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dominant Th1 and Minimal Th17 Skewing in Discoid Lupus Revealed by Transcriptomic Comparison with Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2013.269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}